[
    [
        {
            "time": "2021-11-05",
            "original_text": "AbbVie Presents New Efficacy Data on Upadacitinib (RINVOQ速) in People with Active Psoriatic Arthritis and Axial Involvement at ACR Convergence 2021",
            "features": {
                "keywords": [
                    "AbbVie",
                    "Upadacitinib",
                    "RINVOQ",
                    "Psoriatic Arthritis",
                    "Efficacy Data",
                    "ACR Convergence"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "AbbVie Presents New Efficacy Data on Upadacitinib (RINVOQ速) in People with Active Psoriatic Arthritis and Axial Involvement at ACR Convergence 2021",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 4
            }
        },
        {
            "time": "2021-11-05",
            "original_text": "AbbVie to Present New Long-term Analysis Evaluating the Sustainability of Response to RINVOQ速 (Upadacitinib) Among Patients with Rheumatoid Arthritis",
            "features": {
                "keywords": [
                    "AbbVie",
                    "RINVOQ",
                    "Upadacitinib",
                    "Long-term Analysis",
                    "Sustainability",
                    "Rheumatoid Arthritis"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "AbbVie to Present New Long-term Analysis Evaluating the Sustainability of Response to RINVOQ速 (Upadacitinib) Among Patients with Rheumatoid Arthritis",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 4
            }
        }
    ]
]